Centerpoint Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.95M |
| 2 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
+$2.92M |
| 3 |
iShares S&P Mid-Cap 400 Value ETF
IJJ
|
+$2.87M |
| 4 |
UnitedHealth
UNH
|
+$162K |
| 5 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$48.6K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Growth ETF
IVW
|
+$1.74M |
| 2 |
iShares S&P Mid-Cap 400 Growth ETF
IJK
|
+$1.73M |
| 3 |
iShares S&P Small-Cap 600 Growth ETF
IJT
|
+$1.44M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$38.3K |
| 5 |
ExxonMobil
XOM
|
+$35.6K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.03% |
| 2 | Communication Services | 3.77% |
| 3 | Financials | 3.49% |
| 4 | Consumer Discretionary | 2.61% |
| 5 | Healthcare | 2.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Tempest Therapeutics
TPST
$13.7M
| – | – |
0
| – | – |
|
277
iShares MSCI USA Min Vol Factor ETF
USMV
$23.5B
| $0 | ﹤0.01% |
6
| – | – |
|
|
HEXO
278
DELISTED
HEXO Corp. Common Shares
HEXO
| – | – |
-3
| Closed | -$1K |
|
|
AIG.WS
279
DELISTED
American International Group, Inc.
AIG.WS
| $0 | ﹤0.01% |
16
| – | – |
|
|
WPX
280
DELISTED
WPX Energy, Inc.
WPX
| $0 | ﹤0.01% |
1
| – | – |
|
|
ENT
281
DELISTED
Global Eagle Entertainment Inc.
ENT
| $0 | ﹤0.01% |
14
| – | – |
|
|
JCP
282
DELISTED
J.C. Penney Company, Inc.
JCP
| – | – |
-50
| Closed | – |
|
|
DFRG
283
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| – | – |
-39
| Closed | – |
|
Similar funds
Centerpoint Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, Centerpoint Advisors held 283 positions worth $125M, up 6.2% from $118M the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Centerpoint Advisors deployed $3.9M of net new capital in Q2 2019, opening 13 new positions and adding to 24 existing holdings. Its largest new stake was Agios Pharmaceuticals: 473 shares worth $24K.
By sector, the portfolio is most concentrated in Technology at 4% of assets, up from 3.9% a quarter earlier, followed by Communication Services and Financials.
On the sell side, the largest reduction was iShares S&P 500 Growth ETF, an estimated $1.74M trimmed.
- Centerpoint Advisors's largest Q2 2019 buy was Agios Pharmaceuticals: 473 shares worth $24K.
- Centerpoint Advisors added most to iShares S&P 500 Value ETF in Q2 2019, an estimated $2.95M increase.
- Centerpoint Advisors's biggest Q2 2019 reduction was iShares S&P 500 Growth ETF, cutting an estimated $1.74M.
- Centerpoint Advisors fully exited Lumen in Q2 2019, selling an estimated $6K.
- Centerpoint Advisors's ten largest holdings make up 69% of its $125M portfolio in Q2 2019.
- Centerpoint Advisors opened 13 new positions and closed 5 in Q2 2019.
- Centerpoint Advisors's portfolio value rose 6.2% quarter-over-quarter to $125M.
Based on Centerpoint Advisors's 13F filing for Q2 2019, filed 17 Jul 2019.